| Obsessive-Compulsive Disorder |
1 |
1 |
| Child |
0 |
0.85 |
| Primary Care |
0 |
0.5 |
| Anxiety |
0 |
0.35 |
| Vermont |
0 |
0.28 |
| Anxiety Disorder |
0 |
0.21 |
| Adolescent Medicine |
0 |
0.14 |
| Mental Illness |
0 |
0.14 |
| Mood Disorders |
0 |
0.14 |
| Adverse Effects |
0 |
0.07 |
| Caregiver |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Diagnostic and Statistical Manual of Mental Disorders |
0 |
0.07 |
| Epidemiology |
0 |
0.07 |
| Face |
0 |
0.07 |
| Impulse Control Disorder |
0 |
0.07 |
| Insurance |
0 |
0.07 |
| Pandemic |
0 |
0.07 |
| Preventive Screening |
0 |
0.07 |
| Reuters |
0 |
0.07 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.07 |
| Sleep |
0 |
0.07 |
| Virginia |
0 |
0.07 |